Sort
40,608 grants matching “prostate cancer”
In vivo effects of sulforaphane supplementation on normal human prostate
$454,948Daniel W Lin · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Identifying Diagnostic Markers for Cervical Cancer, Breast Cancer, and Prostate
$454,947Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$454,783Markus Schober · New York University School Of Medicine · R01 · FY2023 · CA
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer
$454,774Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA
RENEW Research-out to ENhancE Wellness Older Survivors
$454,753Wendy Demark-Wahnefried · Duke University · R01 · FY2007 · CA
Ultrasound imaging and enhanced therapeutic response
$454,749Katherine W Ferrara · University Of California At Davis · R01 · FY2015 · CA
Ponce School of Medicine - Moffitt Cancer Center Partnership
$454,725Warren Jackson Pledger · H. Lee Moffitt Cancer Ctr & Res Inst · U56 · FY2010 · CA
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B
$454,712Karen Champagne Glass · Albany College Of Pharmacy · R01 · FY2018 · GM
Visual Sonics Vevo 2100 Imaging System
$454,415Karen H Martin · West Virginia University · S10 · FY2010 · RR
Determine the Microphthalmia Transcription Factor (MITF)-regulated cell rewiring mechanisms in lethal prostate cancer
$454,404Josep Maria Domingo-Domenech · Mayo Clinic Rochester · R01 · FY2025 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$454,400David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Nipple Fluid Hormone Levels and Breast Cancer Risk
$454,396Seema Ahsan Khan · Northwestern University At Chicago · R01 · FY2011 · CA
Molecular Imaging with FACBC PET-CT to Improve Post prostatectomy Radiotherapy
$454,308Ashesh Jani · Emory University · R01 · FY2012 · CA
Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies
$454,280Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Androgen Metabolism in the PCPT
$454,262Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Web-Based Support for Informal Caregivers in Cancer
$454,253David H Gustafson · University Of Wisconsin-Madison · R01 · FY2006 · NR
Development of Methods for a Simplified and Reliable Prostate Cancer MRI Exam
$454,234Stephan E Maier · Brigham And Women'S Hospital · R01 · FY2020 · CA
Targeting mechanisms of radiation resistance
$454,186Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer
$454,179Oliver John Semmes · Eastern Virginia Medical School · U01 · FY2016 · CA
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
$454,144Andrew J Armstrong · Duke University · R01 · FY2022 · CA
Validation of prognostic and pathway signatures in lethal prostate cancer
$454,043Susan Halabi · Duke University · U01 · FY2015 · CA
Human and Computer Mentors for Prostate Cancer Patients
$454,018Robert P Hawkins · University Of Wisconsin-Madison · R01 · FY2008 · CA
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance
$453,967Antonio Fojo · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$453,967Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Post-translational SOX2 modification - a regulatory switch between self-renewal and differentiation in squamous cell carcinoma
$453,875Markus Schober · New York University School Of Medicine · R01 · FY2021 · CA